5 results match your criteria: "4 University College London London[Affiliation]"
Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
May 2018
1 GSK King of Prussia, Pennsylvania.
Reply to Suissa and Ariel: The FULFIL Trial.
Am J Respir Crit Care Med
February 2018
1 GlaxoSmithKline King of Prussia, Pennsylvania.
Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease".
Am J Respir Crit Care Med
October 2017
1 GlaxoSmithKline King of Prussia, Pennsylvania.
Complexity Analysis of Respiratory Dynamics.
Am J Respir Crit Care Med
July 2017
4 University College London London, United Kingdom.